Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Precision Diagnostics Market, by End-use
1.4.2 Europe Precision Diagnostics Market, by Type
1.4.3 Europe Precision Diagnostics Market, by Application
1.4.4 Europe Precision Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul – 2024, May) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Europe Precision Diagnostics Market by End-use
5.1 Europe Clinical Laboratories Market by Country
5.2 Europe Hospitals Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Precision Diagnostics Market by Type
6.1 Europe Genetic Tests Market by Country
6.2 Europe Esoteric Tests Market by Country
6.3 Europe Direct to Consumer Tests Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Precision Diagnostics Market by Application
7.1 Europe Oncology Market by Country
7.2 Europe Respiratory Diseases Market by Country
7.3 Europe CNS Disorders Market by Country
7.4 Europe Immunology Market by Country
7.5 Europe Skin Diseases Market by Country
7.6 Europe Genetic Diseases Market by Country
7.7 Europe Others Market by Country
Chapter 8. Europe Precision Diagnostics Market by Country
8.1 Germany Precision Diagnostics Market
8.1.1 Germany Precision Diagnostics Market by End-use
8.1.2 Germany Precision Diagnostics Market by Type
8.1.3 Germany Precision Diagnostics Market by Application
8.2 UK Precision Diagnostics Market
8.2.1 UK Precision Diagnostics Market by End-use
8.2.2 UK Precision Diagnostics Market by Type
8.2.3 UK Precision Diagnostics Market by Application
8.3 France Precision Diagnostics Market
8.3.1 France Precision Diagnostics Market by End-use
8.3.2 France Precision Diagnostics Market by Type
8.3.3 France Precision Diagnostics Market by Application
8.4 Russia Precision Diagnostics Market
8.4.1 Russia Precision Diagnostics Market by End-use
8.4.2 Russia Precision Diagnostics Market by Type
8.4.3 Russia Precision Diagnostics Market by Application
8.5 Spain Precision Diagnostics Market
8.5.1 Spain Precision Diagnostics Market by End-use
8.5.2 Spain Precision Diagnostics Market by Type
8.5.3 Spain Precision Diagnostics Market by Application
8.6 Italy Precision Diagnostics Market
8.6.1 Italy Precision Diagnostics Market by End-use
8.6.2 Italy Precision Diagnostics Market by Type
8.6.3 Italy Precision Diagnostics Market by Application
8.7 Rest of Europe Precision Diagnostics Market
8.7.1 Rest of Europe Precision Diagnostics Market by End-use
8.7.2 Rest of Europe Precision Diagnostics Market by Type
8.7.3 Rest of Europe Precision Diagnostics Market by Application
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Siemens Healthineers AG (Siemens AG)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.6 SWOT Analysis
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 BioMerieux S.A.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Becton, Dickinson, and Company
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.6 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
Unique Offerings 